NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Micronutrient Supplement for Nurse Burnout

UnknownNA

Sponsor: Nutraceuticals Research Institute

Conditions: Burnout, Professional, Stress, Psychological

Interventions: MagnéVie B6®, Placebo

Countries: United States

The purpose of this study is to confirm and quantify the ability of an 8-week intervention with a supplement containing magnesium citrate and vitamin B6 to reduce anxiety, stress, and burnout among nurses working full time in hospitals and urgent care centers during the COVID-19 Pandemic.

Eligibility overview

Sex: FEMALE

Age: 20 Years to 59 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Provision of signed and dated informed consent form
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Woman aged 20-59
* Lives in the United States
* In good general health as evidenced by medical history
* Stress subscale score from the DASS \> =22
* Ability to take oral medication and be willing to commit to taking 3 tablets a day for 8 weeks.
* For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation and for an additional month after the end of MagnéVie B6® administration
* Employed full time as a nurse in a hospital, primary, or urgent care center that treats COVID-19 patients. Full time is defined as 35 hours or more each week.
* Agreement to adhere to Lifestyle Considerations throughout study duration

Exclusion Criteria:

* Current use of the following pharmaceuticals: bisphosphonates, calcium channel blockers, digoxin, aminoglycoside antibiotics, ketamine, levodopa/carbidopa, gabapentin, potassium sparing diuretics, quinolone antibiotics, skeletal muscle relaxants, sulfonylureas, tetracycline antibiotics, amiodarone, antihypertensives, or antiepileptic drugs (including phenytoin, valproic acid, carbamazepine, phenobarbital).
* Pregnancy, trying to conceive or breastfeeding
* Known allergic reactions to any components of the supplement including magnesium citrate anhydrous, pyridoxine hydrochloride, lactose anhydrous, magnesium stearate, hypromellose, macrogol 6000 titanium dioxide, or talc
* Positive COVID-19 test within 60 days of the study period
* COVID vaccine of any type scheduled during the intervention period or the week prior to the start of the study
* Current diagnosis or lifetime history of a bleeding disorder, kidney disease, or neuromuscular disease
* Recent dramatic weight changes (10% change in body weight in the last 6 months)
* Existing usage of a magnesium or vitamin B6 supplement

Locations (1)

Franklin, Tennessee, United States